cycling NAD+

When people start taking NAD+ supplements, one of the first questions that comes up is whether to take them continuously or to follow something called a cycling protocol, which is a practice of using a supplement for a set period of time and then stopping for a period of time before starting again.

The reason cycling gets recommended as a general precaution comes down to a gap in the research. For many compounds like NAD+ precursors, long-term human studies that look at what happens when you take them for extended periods simply do not exist yet, so researchers and practitioners are working with incomplete information about how the body responds over time.

One of the concerns that drives the cycling recommendation is something called endogenous production suppression, which is the idea that if your body receives a compound from an outside source consistently enough, it may slow down or reduce its own natural manufacturing of that compound. This is a pattern seen with other substances the body produces naturally, and while it has not been definitively proven with NAD+ supplementation specifically, the possibility is enough to warrant caution.

By taking NAD+ for something like twelve weeks and then stepping away from it for a period, a person gives their body a chance to rely on its own production pathways again. This break acts as a kind of reset, and if the body's natural systems are working properly, the expectation is that those pathways will stay active rather than becoming dependent on outside input.

The cycling structure also creates something that uncontrolled self-experimentation badly needs, which is a point of comparison. Most people who are taking NAD+ supplements are doing so outside of any formal study, meaning there is no control group, no blinding, and no way to isolate the supplement as the single variable responsible for any changes they notice.

When someone stops taking a supplement for several weeks and then notices how they feel during that period compared to when they were taking it, they are creating a rough before-and-after picture for themselves. This is not the same as a randomized controlled trial, but it gives a person a personal reference point that they would not have if they just took the supplement indefinitely without ever stopping.

The problem with continuous use is that people naturally adapt to how they feel, so whatever state they are in becomes their new baseline without them realizing it. If someone takes NAD+ every day for a year and feels good, they have no way of knowing whether the supplement is responsible or whether they would feel equally good without it, because they never gave themselves the experience of going without.

Cycling interrupts that process and forces a kind of reassessment. The weeks off become a data collection window where the person is paying attention to energy, cognitive clarity, recovery, or whatever marker they care about, and that attention during the off period makes the return to supplementation more meaningful because there is something to compare it against.

The research landscape around peptides and compounds like NAD+ precursors is also complicated by the fact that most studies that do exist are short in duration, conducted in animal models, or focused on specific disease states rather than general wellness in healthy adults. Translating those findings directly to a healthy person's daily supplementation routine requires some caution because the populations and conditions are different.

This is part of why something called a systematic review, which is a structured method of gathering and evaluating all available studies on a topic to draw broader conclusions, can be helpful for understanding a body of evidence but also has limits when the underlying studies themselves are sparse or inconsistent. When researchers use tools like PubMed, which is a database that indexes biomedical literature from thousands of journals, to look for high-quality evidence on a topic like long-term NAD+ supplementation, they may find that the literature simply does not yet answer the questions most people are actually asking.

In the absence of that evidence, cycling functions as a practical middle ground. It allows a person to continue exploring a compound that has theoretical and preliminary support while building in safeguards and self-assessment opportunities that pure continuous use would not provide.

The twelve-week window that often gets cited is somewhat arbitrary in the sense that it is not derived from a specific study showing that twelve weeks is the threshold where problems begin. It reflects a general principle that a few months of consistent use is long enough to actually evaluate whether something is working and short enough to avoid extended unknown risk.

There is also a psychological dimension to cycling that matters in the context of uncontrolled self-experimentation. When a person commits to evaluating a supplement on a defined timeline, they tend to pay more attention during that period, track their observations more carefully, and make a more deliberate decision about whether to continue rather than simply staying on something out of habit or because stopping feels like an admission that it was not working.

The honest framing here is that cycling NAD+ does not guarantee safety or effectiveness, and it does not replace the kind of controlled research that would actually settle the questions people have about these compounds. What it does is introduce some structure into an otherwise unstructured practice, and that structure creates better conditions for a person to make an informed personal decision based on their own experience rather than assumptions.

---

References

1. Gusenbauer M, Haddaway NR. Which academic search systems are suitable for systematic reviews or meta-analyses? Evaluating retrieval qualities of Google Scholar, PubMed, and 26 other resources. Res Synth Methods. 2020. Source
2. Lindsey WT, Olin BR. PubMed searches: overview and strategies for clinicians. Nutr Clin Pract. 2013. Source
3. Pirani C, Camilleri J. Effectiveness of root canal filling materials and techniques for treatment of apical periodontitis: A systematic review. Int Endod J. 2023. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness